Cancer Drugs Market 2022 to 2028 Latest Industry Trends, Overview of Segments, New Technology and Growth Analysis
Cancer Drugs Market Overview:
The Global Cancer Drugs Market size was valued at USD 135 billion in 2019, and is predicted to reach USD 240 billion by 2030, with a CAGR of 7.45%, from 2020-2030. Cancer is a chronic disease that tends to initiate abnormal growth of cells, leading to formation of tumors, that have tendency to propagate throughout the lymphatic system, blood, and tissues in the human body. There are different types of cancers like lung cancer, stomach cancer, breast cancer, prostate cancer, liver cancer, esophagus cancer, cervical cancer, renal cancer, bladder cancer, and others. Cancer can be diagnosed with the help of various clinical investigations such as CT scans, blood test, biopsy, and others diagnostic options. In early stages of cancer, chemotherapy is used as first-line treatment, and for chronic cancer diseases targeted therapy, immunotherapy as well as a combination of different therapies is used as treatment options.
Market Segmentations:
The global cancer drug market share has been analyzed based on drug class, indication and geography. Based on drug class, the cancer drug market is segmented into chemotherapy, targeted therapy, immunotherapy (Biologic Therapy), and hormonal therapy. Based on indication, the cancer drug market is divided into lung cancer, stomach cancer, colorectal cancer, breast cancer, prostate cancer, liver cancer, esophagus cancer, cervical cancer, kidney cancer, bladder cancer, and other. Geographic breakdown and analysis of each of the previously mentioned segments include regions comprising North America, Europe, Asia-Pacific, and RoW.
Request Sample Report @ https://statisticalinsights.com/sample-request/12-Cancer-Drugs-Market
Segments Overview:
The global Cancer Drugs Market is segmented the drug type and disease indication.
By Drug Type,
Opioids/ Narcotics
Hydromorphone (Dilaudid)
Morphine (Kadian, M-Eslon Others)
Codeine
Oxycodone
Tramadol
Fentanyl
Others
Non-Opioids
Acetaminophen
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Nerve Blocks
The opioids/narcotics segment is estimated to account for the largest market share of approximately 75% owing to the growing prevalence of Cancer Drugs and the growing product pipeline. Within this segment, the codeine sub-segment is expected to witness the highest CAGR of 5.5%. This is because codeine is required in less amount as compared to the other opioids. In addition, the non-opioids segment is estimated to account for a market opportunity of around USD 482.7 million during 2020 to 2030. Within this segment, the non-steroidal anti-inflammatory drugs (NSAIDS) segment is estimated to surpass a market size of USD 1,000 million by 2022. This is because of the low cost as well as easy availability of these drugs.
By Disease Indication,
Lung Cancer
Colorectal Cancer
Breast Cancer
Prostate Cancer
Blood Cancer
Others
A selection of companies mentioned in this report includes:
Astellas Pharma Inc.
AbbVie Inc.
Bristol-Myers Squibb Company
AstraZeneca PLC
F. Hoffmann-La Roche ltd.
Celgene Corporation
Merck & Co., Inc.
Johnson & Johnson (Janssen Global Services, LLC,)
Pfizer Inc.
Novartis AG
Complete Report @ https://statisticalinsights.com/main-report/12-Cancer-Drugs-Market.php
Table of Contents
Chapter 1: Preface
1.1 Report Description
Chapter 2: Executive Summary
2.1 Report Description
2.2 Global Cancer Drugs Market, By Revenue (2018 – 2028) (USD Million)
…
Chapter 9: Global Cancer Drugs Market: Consumer Behavior Analysis
9.1 Consumer Trends & Preferences
9.2 Factors Affecting Buyers Decision
9.3 Key Growth Strategies
Chapter 10: Global Cancer Drugs Market Segmentation: By Product
10.1 Product Overview
10.2 Global Cancer Drugs Market, By Product, Overview/Analysis, 2018-2028
10.3 Global Cancer Drugs Market, By Product, Revenue, Market Share (%), 2018 and 2028 (USD Million)
10.4 Global Cancer Drugs Market Size, By Product, Revenue, 2018-2028 (USD Million)
10.5 Global Cancer Drugs Market Size, By Product, Walnuts, 2018-2028 (USD Million)
10.5.1 Overview/Analysis
10.5.2 Global Cancer Drugs Market Size, By Product, Walnuts, 2018-2028 (USD Million)
10.6 Global Cancer Drugs Market Size, By Product, Hazelnuts, 2018-2028 (USD Million)
Continue…
Related Post :
Moringa Products Market – By Type, By Application, By Distribution Channel, and By Region- global Opportunity Analysis and Industrial Forecast- 2021-2028.
Contact Lenses Market – By Material, By Application, By, By Distribution Channel and By Region- Global Opportunity Analysis and Industrial Forecast- 2020-2028.
About The Statistical Insights
The Statistical Insights is one of the largest collections of market research reports from numerous publishers. We have a team of industry specialists providing unbiased insights on reports to best meet the requirements of our clients. We offer a comprehensive collection of competitive market research reports from a number of global leaders across industry segments. The research reports by The Statistical Insights, are produced by experienced market researchers. Reports will have in-depth analysis about-
CONTACT US
Phone: + (210) 775-2636 (USA)
+ (91) 853 060 7487
Media Contact
Company Name: Statistical Insights
Contact Person: John
Email: Send Email
Phone: (+1) 210-775-2636
Address:Office 709 Pride Icon Kharadi
City: Pune
State: Maharashtra
Country: India
Website: https://www.statisticalinsights.com/
